
A dedicated Oncology Specialist (Board Certification expected Nov 2026) and Medical Advisor at Zula Med, combining extensive clinical experience in Medical and Surgical Oncology with strategic scientific consultancy. Expert in ICD-11 medical classification and data standardization. Passionate about translational research in CAR T-cell therapy, focusing on enhancing T-cell fitness, mitochondrial resilience, and overcoming metabolic barriers in solid tumors.